Related Experiment Videos
[Triterpenoid saponins from bark Mitragyna inermis]
Zhi-hong Cheng1, Bo-yang Yu, Xiu-wei Yang
1National Research Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100083, China.
Summary
Researchers identified novel anti-tumor compounds from Mitragyna inermis. Three quinovic acid glycosides were isolated, with two being new discoveries, showing potential for hepatic carcinoma treatment.
Area of Science:
- Phytochemistry
- Pharmacology
Context:
- Hepatocellular carcinoma (HCC) remains a significant global health challenge.
- Mitragyna inermis is a plant species with a history of traditional medicinal use.
Purpose:
- To investigate the anti-tumor potential of Mitragyna inermis constituents against Bel-7402 human hepatocellular carcinoma cells.
- To isolate and structurally elucidate compounds exhibiting anti-cancer activity.
Summary:
- Three quinovic acid glycosides were successfully isolated from Mitragyna inermis using chromatographic techniques (silica gel, ODS, Sephadex LH-20).
- The structures were confirmed through comprehensive chemical and spectral analyses.
- Two of the isolated compounds, quinovic acid 3 beta-O-beta-D-quinovopyranoside and quinovic acid 3 beta-O-beta-D-glucopyranoside, represent novel discoveries.
Impact:
- This study contributes to the understanding of Mitragyna inermis's chemical profile and its potential as a source of anti-cancer agents.
- The identification of novel quinovic acid glycosides provides new leads for the development of therapeutic strategies against hepatocellular carcinoma.